VMD: Explanation for business results in quarter 3/2012

Vimedimex Medi-Pharma Joint Stock Company (VIMEDIMEX) has explained revenue and profit in quarter 3/2012 as follows:

-         Net revenue increased 37.66% (VND606.02 billion) and cost of goods sold increased 40.40% (VND581 billion).

       Gross profit increased 14.62% (VND25.02 billion) and net profit decreased 69.48% (VND4.87 billion), but Net profit decreased 69.48% (4.87 billion dongs).

       Because the company built distribution system and restructured distribution of imported goods

HOSE

>   PET: Petrosetco withdraws capital from PetroVietnam Packaging (27/11/2012)

>   STT: Satraco Corrects the Resolution of AGM 2011 (27/11/2012)

>   VHC: Explanation for business result in Q3/2012 (27/11/2012)

>   VNI: Explanation for differences in profit in Q3.2012 (parent company) (27/11/2012)

>   BVH: Explanation for consolidated business result in quarter 3/2012 (27/11/2012)

>   HJS: Explanation for the change of over 10% in operating result in QIII.2012 compared to QIII.2011 (27/11/2012)

>   VCS: Explanation for audit exception in semi-annual financial statement 2012 (27/11/2012)

>   NST: Explanation for audit exception in semi-annual financial statement 2012 (27/11/2012)

>   TCT: Explanation for audit exception in semi-annual financial statement 2012 (27/11/2012)

>   PVE: Report on use of proceeds (27/11/2012)